|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▼
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
THIAMAZOLE |
H03BB02 |
DE
|
POM
|
12-07-2022 |
DE/H/0521/002/ |
03-08-2012 |
VALID
|
|
LEVOFLOXACIN |
J01MA12 |
DE
|
POM
|
11-07-2022 |
|
|
VALID
|
|
CIPROFLOXACIN |
J01MA02 |
DE
|
POM
|
29-06-2022 |
DE/H/0587/001/II/001 |
25-02-2010 |
VALID
|
|
FERROUS SULFATE |
B03AA07 |
DE
|
Not subject to prescription
|
27-06-2022 |
DE/H/3789/001/ |
17-12-2014 |
VALID
|
|
ACALABRUTINIB |
L01EL02 |
DE
|
POM
|
26-04-2022 |
|
|
VALID
|
|
BRIGATINIB |
L01ED04 |
DE
|
POM
|
26-04-2022 |
|
|
VALID
|
|
CRIZANLIZUMAB |
B06AX01 |
DE
|
POM
|
26-04-2022 |
|
|
VALID
|
|
LETERMOVIR |
J05AX18 |
DE
|
POM
|
26-04-2022 |
|
|
VALID
|
|
PRASTERONE |
G03XX01 |
DE
|
POM
|
26-04-2022 |
|
|
VALID
|
|
UPADACITINIB |
L04AF03 |
DE
|
POM
|
26-04-2022 |
|
|
VALID
|
|
ABROCITINIB |
D11AH08 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005452 |
09-12-2021 |
VALID
|
|
AMIVANTAMAB |
L01FX18 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005454 |
09-12-2021 |
VALID
|
|
ANIFROLUMAB |
L04AG11 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/004975 |
14-02-2022 |
VALID
|
|
ARTESUNATE |
P01BE03 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005550 |
22-11-2021 |
VALID
|
|
AVACOPAN |
L04AJ05 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005523 |
11-01-2022 |
VALID
|
|
CASIRIVIMAB AND IMDEVIMAB |
J06BD07 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005814 |
12-11-2021 |
VALID
|
|
DAUNORUBICIN |
L01DB02 |
DE
|
POM
|
25-04-2022 |
DE/H/2810/001/ |
29-07-2014 |
VALID
|
|
EPTINEZUMAB |
N02CD05 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005287 |
24-01-2022 |
VALID
|
|
FINERENONE |
C03DA05 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005200 |
16-02-2022 |
VALID
|
|
ISAVUCONAZOLE |
J02AC05 |
DE
|
POM
|
25-04-2022 |
|
|
VALID
|
|
LONAPEGSOMATROPIN |
H01AC09 |
DE
|
Not authorised
|
25-04-2022 |
|
|
VALID
|
|
PEGCETACOPLAN |
L04AJ03 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005553 |
13-12-2021 |
VALID
|
|
PNEUMOCOCCUS, PURIFIED POLYSACCHARIDES ANTIGEN CONJUGATED |
J07AL02 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005451 |
14-02-2022 |
VALID
|
|
PRALSETINIB |
L01EX23 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005413 |
18-11-2021 |
VALID
|
|
REGDANVIMAB |
J06BD06 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005854 |
12-11-2021 |
VALID
|
|
RIPRETINIB |
L01EX19 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005614 |
18-11-2021 |
VALID
|
|
SACITUZUMAB GOVITECAN |
L01FX17 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005182 |
22-11-2021 |
VALID
|
|
SEMAGLUTIDE |
A10BJ06 |
DE
|
POM
|
25-04-2022 |
|
|
VALID
|
|
SOMATROGON |
H01AC08 |
DE
|
Not authorised
|
25-04-2022 |
|
|
VALID
|
|
SOTROVIMAB |
J06BD05 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005676 |
17-12-2021 |
VALID
|
|
TECOVIRIMAT |
J05AX24 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005248 |
06-01-2022 |
VALID
|
|
TIGECYCLINE |
J01AA12 |
DE
|
POM
|
25-04-2022 |
|
|
VALID
|
|
VOXELOTOR |
B06AX03 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/004869 |
14-02-2022 |
VALID
|
|
ZANUBRUTINIB |
L01EL03 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/004978 |
22-11-2021 |
VALID
|
|
GLUCARPIDASE |
V03AF09 |
DE
|
POM
|
29-03-2022 |
|
|
VALID
|
|
SAPROPTERIN |
A16AX07 |
DE
|
POM
|
29-03-2022 |
|
|
VALID
|
|
SITAGLIPTIN |
A10BH01 |
DE
|
POM
|
29-03-2022 |
|
|
VALID
|
|
TAFASITAMAB |
L01FX12 |
DE
|
POM
|
27-01-2022 |
|
|
VALID
|
|
BENPROPERINE |
R05DB02 |
DE
|
POM
|
25-01-2022 |
|
|
VALID
|
|
DICLOFENAC |
M01AB05 |
DE
|
POM + Exemption
|
28-10-2021 |
DE/H/1087/001/MR |
07-11-2008 |
VALID
|
|
CEFTAROLINE FOSAMIL |
J01DI02 |
DE
|
POM
|
19-10-2021 |
|
|
VALID
|
|
COLECALCIFEROL |
A11CC05 |
DE
|
POM
|
18-10-2021 |
DE/H/3675/001/ |
30-09-2014 |
VALID
|
|
IMATINIB |
L01EA01 |
DE
|
POM
|
18-10-2021 |
DE/H/3814/002/ |
23-04-2015 |
VALID
|
|
SIPONIMOD |
L04AE03 |
DE
|
POM
|
18-10-2021 |
|
|
VALID
|
|
EVINACUMAB |
C10AX17 |
DE
|
Not authorised
|
11-10-2021 |
|
|
VALID
|
|
VOSORITIDE |
M05BX07 |
DE
|
Not authorised
|
11-10-2021 |
|
|
VALID
|
|
BIMEKIZUMAB |
L04AC21 |
DE
|
Not authorised
|
08-10-2021 |
|
|
VALID
|
|
DOSTARLIMAB |
L01FF07 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/005204 |
21-04-2021 |
VALID
|
|
DROSPIRENONE AND ESTETROL |
G03AA18 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/005336 |
19-05-2021 |
VALID
|
|
DUVELISIB |
L01EM04 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/005381 |
19-05-2021 |
VALID
|
